Colombia · Medical and donor conditions

Illustration of a clinical review desk with a microscope, medical folder and laboratory glassware.

Colombia: Medical and Donor Requirements for Surrogacy

Colombia’s rules must be read in two layers. The country has binding requirements for assisted-reproduction services and gamete donors, principally Decree 1546 of 1998 and Resolution 3199 of 1998. Those rules do not amount to a complete statutory code for surrogacy or provide one national checklist for every gestational carrier. The Constitutional Court reiterated the regulatory gap in T-127/24. The official materials through 26 October 2026 did not identify a later comprehensive surrogacy statute; bills and proposals are not enacted law. The safe answer is neither “anything goes” nor “every clinic rule is law”: identify the legal source, the person it covers and the clinic’s written protocol before treatment. As of 26 October 2026, the Chamber of Representatives also lists Proyecto de Ley 215/2026C, a proposal to prohibit surrogacy; the project record is not an enacted statute. [S3; S4; S6]

What Colombian law currently settles

In T-968/09 and again in T-127/24, the Constitutional Court described the absence of comprehensive legislation for surrogacy and called for regulation. That is important judicial context, not a medical licence or a complete list of eligibility conditions. The separate assisted-reproduction rules remain relevant: Decree 1546, articles 43–48, regulates reproductive biomedicine units and donor-related matters; Resolution 3199 adds technical and administrative rules. The Court’s discussion of possible safeguards for a future surrogacy law should not be quoted as if Congress had enacted every item. Because the legal position can change, confirm the latest legislation and amendments before relying on this guide. [S1; S2; S3; S4]

Binding donor-selection rules

Under Decree 1546, article 44, a reproductive-biomedicine programme must select healthy donors without genetic alterations that pose a risk of congenital anomalies and must maintain that condition while they remain active in the programme. A donor may not be a minor; have a specified ownership, operational, director or employee relationship with the unit or its cryobank; be the physician referring patients or have a family link with them; or have risk factors for HIV, sexually transmitted infections, or other transmissible infectious or hereditary diseases. Article 45 requires, at minimum, a physical examination, genetic consultation and karyotype, psychological examination, and laboratory testing including viral-antibody testing such as HIV. These are donor rules, not a complete surrogate-carrier code. [S1]

Article 46 provides rejection or discard triggers for donors and/or gametes: ten pregnancies achieved using semen from the same donor; unsatisfactory test results; compromised normal freezing conditions; or proof that the donor is registered with two or more institutions. The ten-pregnancy trigger expressly refers to semen from the same donor; do not extend it automatically to egg donors or treat it as a general maximum for every surrogacy programme. Ask the clinic how it checks donor identity, cross-clinic registration, quarantine and release records, and whether any rejection trigger has occurred. The legal text is old enough that its current application and any later technical updates should be confirmed before treatment. Article 46 also requires rejection where the donor received a blood transfusion within the six months before donation or has any risk factor for HIV, sexually transmitted infections or other infectious diseases. [S1]

Medical tests for donors and recipients

Resolution 3199, article 13, lists minimum tests for both donor and recipient entering a reproductive-biomedicine programme: blood-group classification; syphilis and HIV tests; hepatitis B surface antigen; hepatitis C antibodies; semen and urethral cultures for Neisseria gonorrhoeae and Chlamydia; cytomegalovirus antibodies; mononucleosis testing; and any other tests considered relevant in light of the donor’s and recipient’s region. The article says the listed tests are repeated every six months while the persons remain in the programme and that a donor must be discarded 18 months after entry. As this is a 1998 technical instrument, ask the clinic to explain in writing how it reconciles the text with current laboratory guidance and later applicable standards. Do not rely only on a marketing checklist. [S2; S5]

Quarantine, cryostorage and transport

Articles 47–48 of Decree 1546 add handling requirements that are separate from the test list. For both homologous and heterologous reproductive procedures, gametes and pre-embryos must remain in quarantine until the tests required by articles 45–46 have been medically and laboratory-assessed with satisfactory results. The quarantine must last at least six months, and the material must remain frozen at a temperature no warmer than −196 °C during that period. If frozen semen, ova or pre-embryos are transported, the receiving institution must verify their quality, take responsibility for their stability and quality, and receive them in a suitable container maintaining the specified temperature. Because these provisions date from 1998, ask Colombian counsel and the clinic to confirm their current application alongside later technical standards and the 2025 circular; this paragraph is not a standalone clinical instruction. [S1; S5]

Gestational-carrier criteria: the legal gap

The resolution speaks of a “recipient”; Decree 1546 defines a recipient of gametes or pre-embryos as a woman who receives gametes from a male or female donor, an unfertilized or fertilized ovum, or a pre-embryo for reproductive purposes. The texts do not expressly create a separate, comprehensive medical eligibility code for a gestational carrier in a surrogacy arrangement. A clinician will assess pregnancy fitness and individual risks, but specific age limits, BMI ranges, prior-birth requirements, obstetric-history thresholds, psychological criteria, infectious-disease panels and follow-up schedules need a source: an applicable rule, current professional standard or clinic protocol. Ask which category each criterion belongs to, who interprets abnormal results, when tests expire and whether a second opinion is available. Resolution 3199, article 12, also requires donors and recipients to comply with protocols or management guides adopted by reproductive-medicine units and accepted nationally and internationally. Request the actual dated protocol; this does not turn every internal criterion into a statute. [S1; S2; S3]

T-127/24 discusses elements that commentators have proposed for comprehensive future regulation, including infertility of the intended mother, the carrier not providing the gametes, a non-profit motive, adulthood and psychosocial health, previous childbirth, and examinations before, during and after pregnancy. The Court presents these in its discussion of the legislative gap and possible safeguards; they are not, simply by appearing in the judgment, a self-executing statutory checklist for every current case. Some may be relevant to a clinic’s medical protocol or a court’s assessment of particular facts. Ask for the actual legal provision if a clinic calls one of these criteria “required by Colombian law”; otherwise have it identified honestly as a clinical standard or internal policy. [S3; S4]

Consent, records and donor identity

Resolution 3199, article 17, describes the required consent as “voluntary, free and conscious” in the Spanish text for specified procedures: the donor and institution in heterologous donation, the couple and institution in homologous treatment, and the recipient. This does not mean that one general surrogacy agreement replaces procedure-specific medical consent. Before ovarian stimulation, egg retrieval, insemination, embryo transfer or cryopreservation, ask for forms that explain risks, alternatives, the use and storage or disposal of surplus embryos, data use, donor information and withdrawal rules. The carrier’s consent to medical care and pregnancy-related decisions should be documented separately in language she understands. Do not rely on a verbal assurance that a contract resolves every consent issue. [S2]

Resolution 3199, article 14, requires a confidential donor register. Required details include identity and identity-document information, age and sex, phenotype, spermogram, donation and freezing dates, quarantine and release dates, destination of semen or ova, pregnancies achieved using donor material, and the date and reason for rejecting or discarding a donor; quarantine-control records must also be maintained. Article 15 requires a recipient register with identity, civil status and age, clinical history focused on infertility, general and sexually transmitted infection tests, procedure dates and the origin of gametes or pre-embryos. These are operational duties, not optional marketing extras. Keep your own medical records and consent forms, but do not seek another person’s confidential donor file without a lawful basis. [S2]

Confidential recordkeeping is not the same as a guarantee that a donor is legally anonymous forever. Decree 1546 recognizes both anonymous and known heterologous donors, while Resolution 3199 requires a confidential register. T-127/24 identifies donor identity and the number of offspring among issues requiring broader regulation. The reviewed framework does not justify a clinic promising that future access to donor-origin information is impossible or fully settled. Ask what identity data are retained, who may access them, how long records are kept and what disclosures may be required by law or a later court order. This issue can matter to intended parents, the gestational carrier and the child. [S1; S2; S3]

Importing or exporting gametes and embryos

For cross-border movement, Circular 00000030 of 2025 addresses the entry into or exit from Colombia of male or female gametes, pre-embryos and embryos for assisted reproduction. Only duly habilitated health-service providers (IPS) carrying out assisted-reproduction procedures may handle the movement. They must verify donor informed consent, compliance with donor-selection requirements and transport conditions, and that the transaction does not involve trafficking prohibited by Criminal Code article 134. The IPS must report the entry or exit to INVIMA within 24 hours. The circular says no prior authorisation or official opinion is required from a national, departmental or municipal body, but the reporting duty remains. These rules do not decide the surrogacy agreement’s validity, parentage, citizenship or travel rights. [S5]

Decision matrix: law, protocol and next evidence

SituationBinding baseline / limitationEvidence to request
Donor eligibilityDecree 1546 sets health/genetic criteria, excludes minors and specified conflicts or risks, and requires physical, genetic, psychological and laboratory assessment.Dated screening summary, eligibility decision, test results and traceability records.
Donor rejection limitsArticle 46 lists rejection triggers, including ten pregnancies from the same sperm donor, unsatisfactory tests, compromised freezing or registration at multiple institutions. Article 46 also requires rejection where the donor received a blood transfusion within the six months before donation or has any risk factor for HIV, sexually transmitted infections or other infectious diseases.Written confirmation that no trigger has occurred; do not apply the sperm-specific limit to egg donors without a basis.
Recipient screening and consentResolution 3199 lists minimum donor/recipient tests and consent/register duties; current technical harmonisation needs checking.Test dates and retesting schedule, clinical record, and procedure-specific signed consent.
Gestational carrierNo complete surrogacy-specific statutory medical checklist was identified; Court-discussed future safeguards are not themselves enacted criteria.Written carrier protocol, obstetric/psychosocial assessment, source for each exclusion and review route.
Cross-border movement, quarantine and transportCircular 30/2025 requires a duly habilitated IPS, donor-consent/selection/transport checks and an INVIMA report within 24 hours for cross-border movement. Decree 1546 arts. 47–48 state at least six months of quarantine and −196 °C storage/transport requirements for specified material; confirm current application.Provider habilitation, quarantine/release logs, temperature and chain-of-custody records, consent verification and INVIMA report confirmation.
Donor identity and recordsConfidential donor registers are required, but absolute permanent anonymity and future access to origin data are not fully settled.Written privacy, retention, access and disclosure policy; avoid relying on absolute anonymity promises.

Documents to request before treatment

Before treatment, request in writing: (1) evidence of the clinic’s current health-service habilitation and the exact legal entity performing the procedure; (2) the current donor, recipient and gestational-carrier protocols, with version dates and legal sources; (3) a list of tests, dates, retesting/expiry rules and who reviews abnormal results; (4) separate informed-consent forms for each procedure and each participant; (5) confirmation that donor and recipient registers, quarantine/release logs, cryostorage and chain-of-custody records are maintained; (6) for imported or exported material, transport records, consent verification and confirmation of the INVIMA report; and (7) a written explanation for each exclusion, labelled as statute/regulation, professional standard or clinic policy. Ask the clinic to redact other people’s confidential data rather than disclose their private files. [S1; S2; S5]

Example: a clinic says that every gestational carrier must previously have given birth, be under 35 and fall within a particular BMI range. Ask it to cite the current statute or applicable regulation for each requirement. If no such provision exists, the clinic may still use a medically justified protocol, but it should identify it as policy and explain the evidence and how exceptions are assessed. Conversely, a donor younger than 18 cannot be accepted merely because the clinic approves: Decree 1546 expressly bars minor donors. If imported sperm is used, a valid donor profile alone does not complete Circular 30/2025 compliance; the habilitated provider must also verify consent and transport conditions and report to INVIMA within 24 hours after entry. These distinctions can change whether a proposed treatment can proceed. [S1; S3; S5]

Practical next steps and limits

Next steps: ask Colombian counsel to confirm the current consolidated versions of Decree 1546/1998 and Resolution 3199/1998, any amendments and the present interpretation of the older testing intervals, quarantine/transport requirements and donor limits. Verify that the provider and the specific assisted-reproduction service are currently habilitated. Obtain independent advice on the surrogacy agreement, parentage, donor-origin information and birth-registration steps before signing or embryo transfer. Medical/donor compliance alone does not establish contract enforceability, legal parentage, nationality or permission to travel with a child. [S1; S2; S3; S4]

Official legal, legislative and judicial sources

  1. S1 — Decreto 1546 de 1998 — official consolidated text
  2. S2 — Resolución 3199 de 1998 — Ministry of Health PDF
  3. S3 — Sentencia T-127 de 2024 — Corte Constitucional
  4. S4 — Sentencia T-968 de 2009 — Corte Constitucional
  5. S5 — Circular 00000030 de 2025 — official compilation
  6. S6 — Cámara de Representantes — Proyecto de Ley 215/2026C, official project record (proposal to prohibit surrogacy; not enacted law).

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards